packageDapagliflozin

dapagliflozin

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Dapagliflozin is a blood-glucose-lowering medicine (an SGLT2 inhibitor) used to treat type 2 diabetes, and also heart failure and chronic kidney disease. It is widely used and authorised in the European Union, available both alone and in combination products.

Summary written by glm-5.3-flash from Wikidata Q409898 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:dapagliflozin
ATC codes:A10BK01
DrugBank:DB06292
PubChem CID:9887712
ChEBI:85078
Wikidata:Q409898
formula:C21H25ClO6
molar mass:408.875 g/mol (PubChem CID 9887712)
logP:2.3 (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown